Why Is AZENTA INC (AZTA) Stock Down Today?

Azenta Inc (AZTA) shares fell 10.57% to $43.73 as investors booked profits following a strong earnings report. The stock had previously surged 37.6% over the last eight sessions, reaching a 52-week high before the current pullback.

What Happened

Azenta reported fourth-quarter and full-year fiscal 2026 results that exceeded expectations. Revenue rose 5% to $167 million, beating the estimated $160.133 million. Adjusted earnings per share came in at $0.28, significantly higher than the $0.11 estimate. Despite the strong top-line performance, Multiomics organic sales declined by 1%.

Following the release, several analysts raised their price targets. TD Cowen increased its target to $50 from $33. Needham raised its target to $57 from $37. Jefferies lifted its target to $52 from $44 while maintaining a Buy rating. Management outlined fiscal 2027 sales targets of $648 million to $660 million, compared to an estimate of $639.051 million.

What The Data Shows

The stock opened at $48.55, a 0.7% gap down from the prior close of $48.90. It traded as low as $43.52 near the close of the session. Volume stood at 0.4 million shares, which is 0.5 times the three-month daily average.

Fundamentals show a market cap of $1.8 billion. The company remains unprofitable with a trailing twelve-month EPS of negative $3.50 and a net margin of negative 26.9%. Revenue growth is positive at 4.7% over the trailing twelve months. The stock has a beta of 1.47 and a 52-week range of $15.93 to $50.05. It printed nine fresh 52-week lows on November 12, 2026.

What To Watch

Investors will monitor the company's ability to sustain revenue growth amid Multiomics headwinds. The upcoming fiscal 2027 guidance suggests continued expansion, with sales projected between $648 million and $660 million.